ID: ALA2441069

Max Phase: Preclinical

Molecular Formula: C10H11BrN2O2S

Molecular Weight: 303.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=S1(=O)NCN(C2CC2)c2ccc(Br)cc21

Standard InChI:  InChI=1S/C10H11BrN2O2S/c11-7-1-4-9-10(5-7)16(14,15)12-6-13(9)8-2-3-8/h1,4-5,8,12H,2-3,6H2

Standard InChI Key:  HGEYPDAIHVMWBT-UHFFFAOYSA-N

Associated Targets(non-human)

Glutamate receptor ionotropic, AMPA 2 249 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 303.18Molecular Weight (Monoisotopic): 301.9725AlogP: 1.67#Rotatable Bonds: 1
Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.67CX Basic pKa: CX LogP: 2.08CX LogD: 2.08
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.86Np Likeness Score: -0.73

References

1. Nørholm AB, Francotte P, Olsen L, Krintel C, Frydenvang K, Goffin E, Challal S, Danober L, Botez-Pop I, Lestage P, Pirotte B, Kastrup JS..  (2013)  Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffold.,  56  (21): [PMID:24131202] [10.1021/jm4012092]

Source